165537-93-9

Upstream product

• 32248-43-4 samarium diiodide 
• 134937-92-1 4-benzyl-pyridine; dichromate 
• 165537-90-6 6-(4-Chlorophenylsulfonyl)amino-2-oxo-5,6,7,8-tetrahydro-2H-benzo[e]pyran 
• 23326-27-4 Methyl 2-butynoate 

Downstream Products

• 165537-73-5 3-[6-(4-Chloro-benzenesulfonylamino)-2-methyl-5,6,7,8-tetrahydro-naphthalen-1-yl]-propionic acid 
• 165537-73-5 3-[6-(4-Chloro-benzenesulfonylamino)-2-methyl-5,6,7,8-tetrahydro-naphthalen-1-yl]-propionic acid 
• 165537-95-1 methyl 3-(6-(4-chlorophenylsulfonamido)-2-methyl-5,6,7,8-tetrahydronaphthalen-1-yl)propanoate 
• 165537-94-0 (E)-3-[6-(4-Chloro-benzenesulfonylamino)-2-methyl-5,6,7,8-tetrahydro-naphthalen-1-yl]-acrylic acid methyl ester 

Relevant academic research and scientific papers

Synthesis and biological evaluation of new tetrahydronaphthalene derivatives as thromboxane receptor antagonists

New polysubstituted tetrahydronaphthalene derivatives were prepared as thromboxane receptor (TP-receptor) antagonists. Within this series of compounds S 18886 has been identified as an orally active, highly potent antagonist with a very long duration of action in different species.

1,2,3,4-tetrahydronaphthalene compounds

R1 and R2 form, with the carbon atoms to which they are attached, cyclopentane or cyclohexane, R3 represents hydroxyl, linear or branched (C1 -C6) alkoxy or unsubstituted or substituted amino,